Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrk Us Inc Etf Regulatory News (INCE)

Share Price Information for Frk Us Inc Etf (INCE)

Share Price is delayed by 15 minutes
Get Live Data
10.25    0.006 (0.06%)
Bid:
10.222
Ask:
10.254
Spread: 0.032 (0.313%)
Market Cap: -
INCE Live PriceLast checked at - London Stock Exchange

Intraday Frk Us Inc Etf Share Chart

Completion of Squeeze-out

29 Sep 2017 12:22

RNS Number : 2689S
Gordon Dadds Group PLC
29 September 2017
 

 29 September 2017

GORDON DADDS GROUP PLC (the "Company")

COMPLETION OF SQUEEZE-OUT PROCEDURE AND ALLOTMENT OF ORDINARY SHARES

TOTAL VOTING RIGHTS

 

Further to the announcements on 17 and 18 August 2017 that the Company has exercised the procedure under sections 974-991 of the Companies Act 2006 ("the Act") to acquire, on a compulsory basis, the balance of the Gordon Dadds Shares for which acceptances had not been received pursuant to the Offer by the Final Closing Date of 17 August 2017, the Company announces that it has completed such compulsory acquisition procedure.

 

In accordance with the provisions of the Act, 66,254 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") will be issued to those Gordon Dadds Shareholders who have validly accepted the Offer prior to the expiry of the compulsory acquisition period and 63,220 Ordinary Shares will be allotted and issued to Culver Holdings Limited (previously Gordon Dadds Group Limited) to be held on trust for those Gordon Dadds Shareholders who have not validly accepted the Offer prior to the expiry of the compulsory acquisition period, until such time as they are transferred to such persons.

 

It is expected that 129,474 Ordinary Shares will be admitted to trading on AIM at 8.00 am on 5 October 2017 which Ordinary Shares will, when issued, rank pari passu with all other Ordinary Shares in issue.

 

On admission of the 129,474 Ordinary Shares to trading on AIM on 5 October 2017, the Company's issued share capital will comprise 28,597,310 Ordinary Shares in aggregate. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Unless otherwise stated, terms used in this announcement have the same meanings as given to them in the Offer Document published by the Company and dated 13 July 2017.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Gordon Dadds Group plc

Adrian Biles, Chief Executive Officer

Christopher Yates, Chief Financial Officer

Via Newgate

Arden Partners, Nominated Adviser and broker to the Company

John Llewellyn-Lloyd

Ciaran Walsh

 

+44 (0) 20 7614 5900

Newgate Communications

Adam Lloyd

Lydia Thompson

James Ash

+44 (0) 20 7680 6550

Email: gordondadds@newgatecomms.com

 

Important notice

Arden Partners, which is authorised and regulated in the UK by the FCA, is acting exclusively as nominated adviser and broker to the Company in relation to the matters referred to in this announcement ("Transactions") and no-one else and will not be responsible to anyone other than the Company for providing the protections offered to clients of Arden Partners nor for providing advice in relation to the Transactions.

NOTES:

Gordon Dadds Group plc is an acquisitive legal and professional services business headquartered in London with a significant back office and technology platform based in Cardiff. It operates through two distinct business channels, Gordon Dadds LLP and Prolegal Solicitors Limited, to integrate law firms seeking to gain scale in the UK.

Gordon Dadds: 

Gordon Dadds LLP targets firms with annual fee income of £10m+.

Prolegal:

Prolegal Solicitors Limited acquires and manages firms with £2m - £10m annual fee income. These firms retain their identity and culture and also benefit from the back-office technology platform used by Gordon Dadds which allows Prolegal to target law firms seeking an alternative solution to the regulatory and investment requirements of the UK legal market.

 

The Gordon Dadds model offers a number of advantages to target firms:

· Partners are not required to borrow to fund capital contributions and capital is built up over time out of profit share;

· Each partner receives as their profit share a percentage of his or her personal billings, allowing partners to achieve a significant uplift to what he or she might achieve in a traditional partnership practice;

· The Gordon Dadds model, with its clear division between management and back office on the one hand, and client acquisition and servicing on the other, allows partners to devote time to their respective practice areas; and

· Gordon Dadds Group plc's corporate structure enables partners to acquire and retain an enduring investment in the business through equity ownership.

 

Gordon Dadds LLP has been operating in this way since 2013, successfully integrating firms into its cost efficient platform.

Please visit www.gordondaddsgroup.com for more information.

Contents of this announcement

If you are in any doubt about the contents of this announcement or the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor, accountant or independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident in the United Kingdom, or, if not, from another appropriately authorised independent financial adviser.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEAFFUFWSEFU
Date   Source Headline
15th May 20237:00 amRNSCancellation - INCE GROUP PLC (THE)
28th Apr 20234:20 pmRNSAppointment of administrator and sale of business
13th Apr 20235:45 pmRNSInce Group
13th Apr 20237:00 amRNSResignation of Nominated Adviser and Broker
12th Apr 20232:30 pmRNSIntention to appoint administrator
3rd Apr 20237:00 amRNSChange of Broker
31st Mar 20234:17 pmRNSCompletion of strategic disposals
14th Mar 20232:36 pmRNSUpdate on Financial Results
27th Feb 20237:00 amRNSUpdate on Financial Results
20th Feb 202310:49 amRNSDirector shareholding
10th Feb 20239:16 amRNSReplacement: Update on Financial Results
10th Feb 20237:00 amRNSUpdate on Financial Results
31st Jan 20237:00 amRNSUpdate on Financial Results
27th Jan 20239:54 amRNSStrategic Disposal of Non-Core Practice
16th Jan 20237:00 amRNSCompletion of Arden Partners disposal
12th Jan 20237:00 amRNSArden Partners Disposal Update
3rd Jan 20237:30 amRNSSuspension - The Ince Group plc
3rd Jan 20237:00 amRNSArden Partners disposal - FCA approval received
28th Dec 20225:42 pmRNSHolding(s) in Company
22nd Dec 20225:25 pmRNSUpdate on Financial Results - Suspension of Shares
6th Dec 20224:45 pmRNSHolding in Company
2nd Dec 202211:12 amRNSHolding(s) in Company
1st Dec 20225:56 pmRNSHolding(s) in Company
1st Dec 20225:27 pmRNSHolding(s) in Company
30th Nov 20225:00 pmRNSTotal Voting Rights
24th Nov 20227:00 amRNSResult of Placing and REX Retail Offer and TVR
23rd Nov 20224:58 pmRNSREX Retail Offer for up to £0.25 million
23rd Nov 20224:55 pmRNSProposed Placing, Retail offer and Trading Update
16th Nov 20227:00 amRNSConditional disposal of Arden Partners plc
9th Nov 20227:00 amRNSBoard Appointment
7th Nov 20223:06 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSHolding(s) in Company
31st Oct 20225:00 pmRNSTotal Voting Rights
17th Oct 202210:56 amRNSEmployee subscription, director holding & TVR
14th Oct 20221:27 pmRNSHolding(s) in Company
13th Oct 20221:38 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSCost rationalisation programme update
7th Oct 20227:00 amRNSSubscription for shares, holding in Company & TVR
4th Oct 202211:21 amRNSHolding(s) in Company
3rd Oct 20227:00 amRNSProposed disposal of Gibraltar subsidiaries
30th Sep 20225:00 pmRNSTotal Voting Rights
30th Sep 202212:19 pmRNSResult of AGM
30th Sep 20227:00 amRNSTrading Update
28th Sep 20227:00 amRNSRelated party transaction
15th Sep 20227:00 amRNSDisposal of CW Energy LLP
12th Sep 20227:00 amRNSBoard and Senior Management Change
8th Sep 202211:02 amRNSTR-1
7th Sep 202212:34 pmRNSTR-1
6th Sep 20225:05 pmRNSNotice of AGM and Annual Report & Accounts update
1st Sep 20227:00 amRNSSubscription for shares and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.